noscript

News and Announcements

Imugene’s Cancer Vacine Recieves Grant Notice from Canadian Patent Office

  • Published August 18, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Imugene Limited (ASX:IMU) has recently announced news it has received notice that the Canadian Patent Office has issued a Grant Notice for the Company’s cancer vaccine HER-Vaxx.

KEY TAKEAWAYS: 

  • Canadian Patent Office has issued Grant Notice for Imugene’s patent application protecting its cancer vaccine “HER-Vax”
  • Patent will protect specific cancer vaccine formulations of commercial interest

HER-Vaxx works by targeting the same receptor as Herceptin and Perjeta, two of the leading drugs on the market, with annual sales of US$8.2 billion. The mechanism of action for HER-Vaxx may help generate improved efficacy over existing treatments and at a lower cost.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now